C’est devant un parterre de personnalités politiques et de responsables de la célèbre entreprise biopharmaceutique que GSK Wavre a lancé le chantier de construction de sa nouvelle unité de ...
Luminus, a présenté son projet lors d'une réunion d'information ce mardi soir à la Sucrerie: deux nouvelles éoliennes dont la ...
GSK est également présent en Belgique. Le groupe emploie 9.000 personnes sur trois sites de production de vaccins en Wallonie (Wavre, Rixensart et Gembloux), parmi lesquels se trouve le siège ...
Bloomberg on MSN8mon
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer ...
Eli Lilly made a $2.5 billion deal for a breast cancer drug; GSK reached a $1 billion-plus deal for IDRx. The announcements suggest a potential rebound in M&A deals in the healthcare sector for 2025.
Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...
In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal cancer asset. “We really became impressed with what IDRx had achieved ...
GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio. The purchase ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK is nearing a $1bn deal to buy a US biotech developing a treatment for rare gastrointestinal tumours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback